Cervical cancer prevention: New tools and old barriers

Cancer

Volumn 116, Issue 11, 2010, Pages 2531-2542

  Scarinci, Isabel C ^a,b   Garcia, Francisco A R ^c   Kobetz, Erin ^d   Partridge, Edward E ^b   Brandt, Heather M ^e   Bell, Maria C ^f   Dignan, Mark ^g   Ma, Grace X ^h   Daye, Jane L ⁱ   Castle, Philip E ⁱ  

^a and Clinical Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

^f Sanford Women's Health   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical cancer; Cervical cancer prevention; Human papillomavirus testing; Human papillomavirus vaccination

Indexed keywords

WART VIRUS VACCINE;

AFRICAN AMERICAN; ASIAN AMERICAN; CANCER INCIDENCE; CANCER PREVENTION; CONDYLOMA ACUMINATUM; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGH RISK POPULATION; HISPANIC; HUMAN; IMMIGRANT; PAPANICOLAOU TEST; PERSONAL HYGIENE; PRIORITY JOURNAL; REVIEW; SCREENING; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

AFRICAN AMERICANS; EARLY DETECTION OF CANCER; FEMALE; HAITI; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; PAPILLOMAVIRUS VACCINES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIETNAM;

EID: 77952837934     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25065     Document Type: Review

References (78)

1. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672-1694.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
4. Centers for Disease Control and Prevention. Cervical Cancer. 2009. Available at: http://www.cdc.gov/cancer/cervical/ Accessed April 9, 2009.
5. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Program. 2009. Available at: http://www.seer.cancer.gov Accessed April 9, 2009.
6. Wright TC Jr, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med. 2003;348:489-490. (Pubitemid 36159883)
7. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:425-434.
8. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928-1943. (Pubitemid 46740303)
9. Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.
10. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double- blind, randomised controlled trial. Lancet. 2007;369: 2161-2170.
11. Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298:743-753.
12. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003;362:1871-1876.
13. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119: 1095-1101.
14. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006;24(suppl 3):S3/78-S3/89.
15. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol. 2006;7:547-555. (Pubitemid 43923665)
16. Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006;98: 765-774. (Pubitemid 43983300)
17. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003; 95:46-52.
18. Kjaer S, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006;66:10630-10636. (Pubitemid 44799787)
19. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007; 370:1764-1772. (Pubitemid 350137476)
20. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579-1588. (Pubitemid 47598400)
21. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357:1589-1597. (Pubitemid 47598401)
22. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008;100:492-501.
23. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360:1385-1394.
24. Schiffman M, Wacholder S. From India to the world-a better way to prevent cervical cancer. N Engl J Med. 2009;360: 1453-1455.
25. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data. 2005; 1-55.
26. Castle PE, Fetterman B, Akhtar I, et al. Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009;114:365-369.
27. Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities. NIH Pub. No. 05-5282. Bethesda, MD: National Institutes of Health; 2007.
28. Centers for Disease Control and Prevention. United States Cancer Statistics. 2009. Available at: http://apps.nccd.cdc.gov/uscs/ Accessed April 9, 2009.
29. Matthews AK, Berrios N, Darnell JS, Calhoun E. A qualitative evaluation of a faith-based breast and cervical cancer screening intervention for African American women. Health Educ Behav. 2006;33:643-663. (Pubitemid 44310485)
30. Brandt HM, Modayil MV, Hurley D, et al. Cervical cancer disparities in South Carolina: an update of early detection, special programs, descriptive epidemiology, and emerging directions. J S C Med Assoc. 2006;102:223-230.
31. Partridge EE, Fouad N, Hinton A, et al. The deep South network for cancer control: eliminating cancer disparities through community-academic collaboration. Fam Community Health. 2005;28:6-19.
32. Freire P. Pedagogia do oprimido. Rio de Janeiro, Brazil: Paz e Terra, 1987.
33. Wallerstein N, Duran B. The conceptual, historical, and practice roots of community based participatory research and related participatory traditions. In: Minkler M, Wallerstein N, eds. Community-Based Participatory Research for Health. San Francisco, Calif: Jossey-Bass; 2003:27-52.
34. Lisovicz N, Johnson RE, Higginbotham J, et al. The Deep South Network for cancer control. Building a community infrastructure to reduce cancer health disparities. Cancer. 2006;107:1971-1979.
35. Florida Cancer Data System (FCDS). Cervical Cancer Incidence and State of Diagnosis Among Women in Miami- Dade County. Miami, FL: University of Miami, Miller School of Medicine, Florida Cancer Data System; 2004.
36. Kobetz E, Menard J, Barton B, Pierre L, Diem J, Auguste PD. Patne en Aksyon: addressing cancer disparities in Little Haiti through research and social action. Am J Public Health. 2009;99:1163-1165.
37. Kobetz E, Menard J, Diem J, et al. Community-based participatory research in Little Haiti: challenges and lessons learned. Prog Community Health Partnersh. 2009;3:133-137.
38. Israel B, Schultz A, Parker E, Becker A, Allen A, Guzman R. Developing and Following Community Based Research Principles. San Francisco, Calif: Jossey-Bass; 2003.
39. Stepick A. Pride Against Prejudice: Haitians in the United States. Boston: Allyn & Bacon; 1998.
40. Farmer P. AIDS and Accusation: Haiti and the Geography of Blame. Berkeley, Calif: University of California Press; 1992.
41. Minkler M, Wallerstein N (eds). Community-Based Participatory Research for Health. San Francisco, Calif: Jossey- Bass; 2003.
42. American Cancer Society. Cancer Facts & Figures for Hispanics/Latinos 2009-2011. Atlanta, GA, 2009.
43. U.S.-Mexico Border Health Commission. Healthy Border 2010: An Agenda for Improving Health on the United States-Mexico Border. Washington, DC: U.S.-Mexico Border Health Commission; 2003.
44. Williams MA, Mokry B, Risser D. Cervical Cancer in Texas 2006. Austin, TX: Texas Department of State Health Services; 2006.
45. Coughlin SS, Richards TB, Nasseri K, et al. Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003. Cancer. 2008;113:2964-2973.
46. Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican- American women. J Natl Cancer Inst Monogr. 1995; 41-47.
47. Fernandez-Esquer ME, Espinoza P, Ramirez AG, McAlister AL. Repeated Pap smear screening among Mexican-American women. Health Educ Res. 2003;18:477-487. (Pubitemid 36988130)
48. Fernandez-Esquer ME, Cardenas-Turanzas M. Cervical cancer screening among Latinas recently immigrated to the United States. Prev Med. 2004;38:529-535. (Pubitemid 38452878)
49. Leybas-Amedia V, Nuño T, Garcia F. Effect of acculturation and income on Hispanic women's health. J Health Care Poor Underserved. 2005;16:128-141. (Pubitemid 41820327)
50. Buki LP, Jamison J, Anderson CJ, Cuadra AM. Differences in predictors of cervical and breast cancer screening by screening need in uninsured Latino women. Cancer. 2007; 110:1578-1585. (Pubitemid 47463073)
51. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer. 2007;109:348-358.
52. Wallace D, Hunter J, Papenfuss M, de Zapien JG, Denman C, Giuliano AR. Pap smear screening among women >/=40 years residing at the United States-Mexico border. Health Care Women Int. 2007;28:799-816.
53. Larkey L. Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. J Community Health. 2006;31:69-77. (Pubitemid 43042755)
54. Fernandez-Esquer ME, Espinoza P, Torres I, Ramirez AG, McAlister AL. A su salud: a quasi-experimental study among Mexican American women. Am J Health Behav. 2003;27: 536-545. (Pubitemid 38146651)
55. Garcia F, Barker B, Santos C, et al. Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus. Obstet Gynecol. 2003;102:266-272. (Pubitemid 36936997)
56. Seeff LC, McKenna MT. Cervical cancer mortality among foreign-born women living in the United States, 1985 to 1996. Cancer Detect Prev. 2003;27:203-208.
57. Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res. 2008;18:584-596. (Pubitemid 351546649)
58. Lehman R. Invasive Cervical Cancer Among American Indians in the Northern Plains, 1994-1998: Incidence, Mortality, and Missed Opportunities. Washington, DC: Indian Health Service; 2002.
59. McSwain R. Network for Cancer Control Research Among Native American and Alaska Native Populations. Washington, DC: Department of Health and Human Services/Indian Health Service; 2008. Available at: http://www.ihs.gov/ publicinfo/publicaffairs/director/2008-Statements/FinalSpeech- NativeCIRCLEmeeting.pdf Accessed April 22, 2009.
60. Bell MC, Schmidt-Grimminger D, Patrick S, Ryschon T, Linz L, Chauhan SC. There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains. Gynecol Oncol. 2007;107:236-241. (Pubitemid 47575718)
61. Cancer Incidence/Mortality Rates in Kentucky. Lexington, KY: Kentucky Cancer Registry; 2009. Available at: http://www.kcr.uky.edu Accessed April 21, 2009.
62. Miller BA, Kolonel LN, Bernstein L, et al. Racial/Ethnic Patterns of Cancer in the United States 1988-1992. NIH Pub. No. 96-4104. Bethesda, MD: National Institutes of Health; 1996.
63. Shive SE, Ma GX, Tan Y, Toubbeh J, Parameswaran L, Halowich J. Health information and cancer screening differences among Asian Americans. CA J Health Promot. 2006;4: 1-11.
64. Shive SE, Ma GX, Tan Y, Toubbeh J, Parameswaran L, Halowich J. Racial differences in preventive and complementary health behaviors and attitudes. J Health Disparities Res Pract. 2006;1:75-92.
65. Sadler GR, Dong HS, Ko CM, Luu TT, Nguyen HP. Vietnamese American women: breast cancer knowledge, attitudes, and screening adherence. Am J Health Promot. 2001; 15:211-214, ii.
66. McPhee SJ, Stewart S, Brock KC, Bird JA, Jenkins CN, Pham GQ. Factors associated with breast and cervical cancer screening practices among Vietnamese American women. Cancer Detect Prev. 1997;21:510-521. (Pubitemid 27518939)
67. Ma GX, Tan Y, Toubbeh JI, et al. Asian Tobacco Education and Cancer Awareness Research Special Population Network. A model for reducing Asian American cancer health disparities. Cancer. 2006;107:1995-2005.
68. Fang CY, Ma GX, Tan Y, Chi N. A multifaceted intervention to increase cervical cancer screening among underserved Korean women. Cancer Epidemiol Biomarkers Prev. 2007;16: 1298-1302. (Pubitemid 46991961)
69. Schiffman M, Castle PE. The promise of global cervicalcancer prevention. N Engl J Med. 2005;353:2101-2114.
70. Marlow LAV, Waller J, Evans REC, Wardle J. Predictors of interest in HPV vaccination: a study of British adolescents. Vaccine. 2009;27:2483-2488.
71. Santry C. Muslim girls may miss out on cervical cancer immunisation. Health Serv J. 2008;4:4.
72. Warraich HJ. Religious opposition to polio vaccination. Emerg Infect Dis. 2009;15:978.
73. Daniels NA, Juarbe T, Moreno-John G, Perez-Stable EJ. Effectiveness of adult vaccination programs in faith-based organizations. Ethn Dis. 2007;17(1 suppl 1):S15-S22.
74. Shafi S, Rashid H, Ali K, et al. Influenza vaccine uptake among British Muslims attending Hajj, 2005 and 2006. BMJ. 2006;333:1220.
75. Omer SB, Pan WK, Halsey NA, et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA. 2006;296:1757-1763.
76. Brotherton JM, Deeks SL, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell. 2008;32:457-461.
77. Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust N Z J Public Health. 2009;3:365-370.
78. Weisberg E, Bateson D, McCaffery K, Skinner SR. HPV vaccination catch up program - utilisation by young Australian women. Aust Fam Physician. 2009;38:72-76.